Navigation Links
Researchers investigate links between prostate, cadmium, zinc
Date:1/30/2008

Cadmium exposure is a known risk factor for prostate cancer, and a new University of Rochester study suggests that zinc may offer protection against cadmium.

In an article published in the February 2008 journal, The Prostate, epidemiologist Edwin van Wijngaarden, Ph.D., reports that PSA levels were 22 percent higher among American men who had zinc levels below the median (less than 12.67 mg/daily) and cadmium levels above the median. (PSA is a protein produced by the cells of the prostate gland. The higher a mans PSA level, the more likely cancer is present.)

In contrast, among men with a greater than median zinc intake, little evidence of an association between cadmium and PSA was found.

The way zinc and cadmium interact within human organs is significant and provides interesting leads for study, van Wijngaarden said. Zinc stimulates production of a protein that binds cadmium thereby taking it out of circulation and reducing its toxic effects.

However, it is too early to recommend zinc supplements for those whore worried about prostate damage, he added.

Your health is based on the complex interplay of many factors, said Van Wijngaarden, an assistant professor in the Department of Community and Preventive Medicine at the University of Rochester Medical Center. Environmental exposures play out differently in people. Its important to identify those subpopulations that may be more sensitive to toxicities.

The study was based on data from a sample of 1,320 men registered in the National Health and Nutrition Examination Survey (NHANES) 2001-2002, which was the first time PSA levels were available. In men over age 40, urinary cadmium levels were measured in about one-third of the sample and dietary zinc intake was reported based on 24-hour recall. Information on all three variables was available for a total of 422 men.

Cadmium exposure occurs mostly through smoking and diet, the latter as a result of fertilizer-soaked soil used for growing crops. Cadmium is also a byproduct of the industrial process used for making fungicides, batteries, pigments and coatings that protect metals from corrosion. Workers in those areas are at risk for much higher exposures. When ingested or inhaled, cadmium collects in the liver, kidneys and prostate.

Prostate cancer is the most frequently diagnosed non-skin malignancy in the United States. Nearly 219,000 new cases and 27,000 deaths were expected in 2007.

Zinc is an important nutrient to maintain health. However, the jury is still out on the benefits of large quantities zinc and van Wijngaarden cautioned that some studies show it may do more harm than good when taken as a dietary supplement. Zinc toxicity can harm the immune system, reduce beneficial cholesterol, and alter iron function.

This type of inconsistency may be explained by variability in certain populations, he said. Epidemiologists often focus on single exposures, but biology is not that simple. The latest research suggests we should be studying the interplay of exposures on certain subgroups of people and how they vary.


'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. New nanotube findings by Stanford researchers give boost to potential biomedical applications
2. Researchers Map Paths Governing Neuron Function
3. Cold Spring Harbor Laboratory researchers race against time to save Tasmanian devils
4. Researchers at Peoria Pulmonary Associates to study airway bypass procedure for emphysema
5. Pain medicine meeting unites top researchers and clinicians
6. Researchers identify brains eureka circuitry
7. Researchers find relief for chronic pain
8. Researchers propose consumers buy yearly drug licenses as new way to pay for prescriptions
9. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
10. DOE awards supercomputing time to UCSD, SDSC researchers
11. Argonnes Blue Gene/P to host large cadre of INCITE researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... San Francisco, CA (PRWEB) , ... January 19, 2017 , ... ... and financial planning assistance to commercial and residential clients in the California Bay Area, ... promote positive heart health in the region. , Heart disease is the primary killer ...
(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Connecticut Dermatology Group ... Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background ... , “It is with considerable pleasure to welcome back Dr. Kim to the CDG ...
(Date:1/19/2017)... ... 19, 2017 , ... Each year, the Southeastern Society of ... hundreds of surgeons from over fifteen different countries come together to share and ... augmentation to breast reconstruction for breast cancer patients, teaching these surgical techniques ...
(Date:1/18/2017)... ... 2017 , ... From a health perspective, 2017 will clearly be the Year ... chronic disease, mental health and general physical well-being. The New York Times suggested a ... , For one Charlottesville restaurant, good gut health is clearly on the menu. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  ViewRay, Inc. (Nasdaq: VRAY ... clinical MRI-guided radiation therapy system, announced today that it ... million through a private placement of its common ... financing and was joined by certain of ViewRay,s ... Venture Partners, and an additional new institutional investor, ...
(Date:1/19/2017)... ROCKVILLE, Md. , Jan. 18, 2017 /PRNewswire/ ... a late-stage clinical company developing therapeutics designed to ... health of patients, today confirmed plans to initiate ... the Company,s modified-release reformulation of lovastatin lactone designed ... M. smithii) in the gut to treat ...
Breaking Medicine Technology: